Skip to main content
Search
Explore journals
Get published
About BMC
My account
Search all BMC articles
Search
BMC Cancer
Home
About
Articles
Submission Guidelines
Collections
Join the Board
Submit manuscript
Article metrics
Last updated: Sat, 4 May 2024 5:46:24 Z
A randomized phase II trial to elucidate the efficacy of capecitabine plus cisplatin (XP) and S-1 plus cisplatin (SP) as a first-line treatment for advanced gastric cancer: XP ascertainment vs. SP randomized PII trial (XParTS II)
